Glenmark Pharmaceuticals Sees 11,611 Call Contracts at Rs 1900 Strike Price Traded Today

Glenmark Pharmaceuticals Ltd. has emerged as one of the most active stocks today, particularly in the options market. The company, operating within the Pharmaceuticals & Biotechnology sector, has seen significant trading activity in call options set to expire on November 25, 2025. Notably, the call option with a strike price of Rs 1900 led the activity with 11,611 contracts traded, generating a turnover of approximately Rs 1,102.90 lakhs and an open interest of 2,866 contracts.
Other active strike prices included Rs 1840, with 5,377 contracts traded and a turnover of Rs 987.02 lakhs, and Rs 1860, which saw 5,988 contracts traded for a turnover of Rs 857.78 lakhs. The strike price of Rs 2000 also attracted attention, with 6,214 contracts traded and a turnover of Rs 188.28 lakhs.

In terms of performance, Glenmark's stock has underperformed its sector by 3.21%, following a trend reversal after three consecutive days of gains. The stock opened down by 2.14% today, reaching an intraday low of Rs 1810, reflecting a decline of 4.52%. Despite these challenges, the stock remains liquid, with a delivery volume of 8.4 lakhs on November 14, marking a 39.51% increase compared to the five-day average.

Overall, Glenmark Pharmaceuticals continues to be a focal point in the market, driven by notable trading volumes and a dynamic options landscape.